Netflix Whiffs on Member Growth
Should investors be worried?
Editors' Picks
The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On
Gene therapy developers might steal all of the headlines, but manufacturing is likely to be the more lucrative investing opportunity -- for both companies and investors.
CSX Cuts Its Growth Outlook on Economic Uncertainty
Prospects for full-year revenue growth just grew dimmer.
3 Top Artificial Intelligence Stocks to Watch in July
AI is expected to add $13 trillion to the global economy by 2030. These three stocks are in the forefront of its growth.
Recent articles
Facebook Is Getting Closer to This Massive Opportunity in India
After over a year of beta testing, Facebook may be getting ready to launch WhatsApp payments nationwide.
Slack CEO Has Been Selling Shares Literally Every Day
Here's why investors shouldn't fret too much about it.
Curaleaf Makes an $875 Million Deal, Stock Up 17.5%
The company will be the new owner of GR Companies (Grassroots).
Why Nu Skin Enterprises Stock Dropped Today
The multilevel marketing company just reduced its full-year outlook. Here's why.
Apple's Next Move to Take on Spotify
The iPhone maker might invest in some slightly different original content.
Netflix Whiffs on Member Growth
Should investors be worried?
J.B. Hunt Maintains Top-Line Growth in a Challenging Quarter
The freight logistics company also projects more progress on the profitability front over the next two quarters.
Not Getting Hired? Here Are 4 Things You May Be Doing Wrong
Simple mistakes can get your resume sent to the reject pile.
What Happened in the Stock Market Today
See why CSX dropped and Cintas popped on a down day for the broader markets.
ASML Overcomes Memory-Chip Weakness
The company sees strong demand from logic customers driving growth this year.
Here's What We Know About the Peloton IPO
The fitness company hasn't revealed many hard numbers yet, but market trends say a lot about its long-term potential.
Starbucks Earnings: What to Watch
Can the coffee giant keep up strong comparable-store sales growth and maintain its momentum in China?
Why Textron, Nu Skin Enterprises, and Ericsson Slumped Today
These stocks helped contribute to the broader market's losses.
Why Seattle Genetics, AVROBIO, and First Majestic Silver Jumped Today
Despite declines in the broader market, good news lifted shares of these companies.
Why MACOM Technology Stock Popped 12% Wednesday
An analyst's upgrade buoyed investors' hopes for a turnaround at the semiconductor product specialist.
Textron Loses Altitude as Revenue Declines
An underwhelming top line overshadowed the industrial conglomerate's continued earnings growth.
Department of Justice Wants to Pause Qualcomm Ruling
The DOJ antitrust division thinks Qualcomm will win its appeal of the FTC ruling.
Is Uber a Buy?
The leading ride-hailing service is a broken IPO, but you can't get in the way of a moving car when it's heading in the right direction.
The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On
Gene therapy developers might steal all of the headlines, but manufacturing is likely to be the more lucrative investing opportunity -- for both companies and investors.
Netflix Looks to Build on Its Success in India
The streaming giant is getting its act together in a lucrative video streaming market that could be worth $5 billion in the next five years.